InvestorsHub Logo
Followers 36
Posts 1543
Boards Moderated 0
Alias Born 08/19/2000

Re: None

Thursday, 10/19/2000 8:45:14 PM

Thursday, October 19, 2000 8:45:14 PM

Post# of 82595
Advantages

As one of the first practitioners in the new field of Phenomics, we
hold distinct advantages.

Our advantages are:

1.We have developed and patented a proprietary biochemical
reagent (TruSeqTM) for high-throughput genetic analysis using
a DNA chip based or electrophoresis based platform
technology.
2.We are forming strategic alliances with other genomics and
pharmacogenomics companies, for access to raw materials and
intellectual property, lowering our R and D basis.
3.We are assembling a proprietary collection of LIMS (FEMSTM)
and heuristic software tools for a revolutionary data mining
process specially suited for Phenomics applications.
4.We are compiling unique SNP databases for target phenotypes
and diseases. Our proprietary data mining routines capitalize
on the newness of high-throughput genotyping technology and
the recent completion of the human genome project.




Copyright DNAprint genomics © 2000